PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Mojeaga remedy (blend of A. cordifolia, Pennisetum glaucum, and Sorghum bicolor) used as an adjunct to conventional iron therapy [PMID:37155690]
A crossover study evaluated the effect of A. cordifolia on the glycemic indices of varieties of fufu in healthy subjects [PMID:38328775]
Lipophilic leaf fractions showed significant topical anti-inflammatory effects in mice ear oedema models, outperforming indomethacin [PMID:21707250]
Hydroethanolic leaf extract showed anti-arthritic activity in CFA-induced arthritic rats [PMID:25435626]
Extracts showed broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria, including S. aureus and E. coli [PMID:10189955, PMID:26724423, PMID:11163946]
Evidence summary
PubMed sources
- 1.PMID: 27296085 (2016) — Recent trends in phytochemistry, ethnobotany and pharmacological significance of Alchornea cordifolia (Schumach. & Thonn.) Muell. Arg. · Journal of ethnopharmacology
- 2.PMID: 38328775 (2024) — Effect of Alchornea cordifolia on Glycemic Indices of Varieties of Fufu Among Healthy Subjects. · Current developments in nutrition
- 3.PMID: 35456270 (2022) — Isolation and Characterisation of Quercitrin as a Potent Anti-Sickle Cell Anaemia Agent from Alchornea cordifolia. · Journal of clinical medicine
- 4.PMID: 36618915 (2022) — Assessment of toxicity and anti-plasmodial activities of chloroform fractions of Carapa procera and Alchornea cordifolia in murine models. · Frontiers in pharmacology
- 5.PMID: 36926684